ARSD
Basic information
Region (hg38): X:2903972-2929349
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ARSD gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 29 | 12 | 44 | |||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 4 | |||||
Total | 0 | 0 | 30 | 20 | 4 |
Variants in ARSD
This is a list of pathogenic ClinVar variants found in the ARSD region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
X-2907318-G-A | not specified | Uncertain significance (May 22, 2023) | ||
X-2907322-G-A | Benign (Mar 29, 2018) | |||
X-2907437-G-T | ARSD-related disorder • not specified | Uncertain significance (Mar 14, 2023) | ||
X-2907438-C-T | ARSD-related disorder • not specified | Uncertain significance (Mar 14, 2023) | ||
X-2907455-G-C | not specified | Uncertain significance (Jun 22, 2023) | ||
X-2907471-G-A | not specified | Uncertain significance (May 08, 2023) | ||
X-2907540-C-T | not specified | Uncertain significance (Jan 12, 2024) | ||
X-2907555-C-T | Benign (Mar 29, 2018) | |||
X-2907585-C-T | not specified | Uncertain significance (Aug 13, 2021) | ||
X-2907624-C-T | not specified | Uncertain significance (Jun 07, 2023) | ||
X-2908724-C-G | not specified | Uncertain significance (Jan 24, 2024) | ||
X-2908745-C-T | not specified | Uncertain significance (Oct 20, 2023) | ||
X-2909889-C-T | Benign (Mar 29, 2018) | |||
X-2909935-C-T | not specified | Uncertain significance (Feb 28, 2024) | ||
X-2910704-T-C | not specified | Uncertain significance (Apr 08, 2024) | ||
X-2910769-T-G | not specified | Uncertain significance (Jun 22, 2024) | ||
X-2914627-A-G | ARSD-related disorder | Likely benign (Jul 31, 2020) | ||
X-2914655-T-C | ARSD-related disorder | Likely benign (Jul 31, 2020) | ||
X-2914674-T-C | ARSD-related disorder | Likely benign (Jul 31, 2020) | ||
X-2914746-A-G | ARSD-related disorder | Likely benign (Jul 31, 2020) | ||
X-2915564-C-T | ARSD-related disorder | Likely benign (Jul 31, 2020) | ||
X-2915565-A-C | not specified | Uncertain significance (May 04, 2023) | ||
X-2915587-A-C | Likely benign (Mar 28, 2018) | |||
X-2915590-A-G | Likely benign (Mar 28, 2018) | |||
X-2915597-C-T | ARSD-related disorder | Likely benign (Jul 31, 2020) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ARSD | protein_coding | protein_coding | ENST00000381154 | 10 | 25382 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00163 | 0.973 | 125687 | 13 | 48 | 125748 | 0.000243 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.09 | 199 | 247 | 0.805 | 0.0000211 | 3811 |
Missense in Polyphen | 53 | 82.283 | 0.64412 | 1387 | ||
Synonymous | 0.704 | 109 | 119 | 0.918 | 0.0000121 | 1194 |
Loss of Function | 1.97 | 7 | 15.3 | 0.457 | 0.00000119 | 251 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00198 | 0.00198 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000513 | 0.0000352 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000223 | 0.000131 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Pathway
- Estrogen metabolism;Metabolism of lipids;Post-translational protein modification;Metabolism of proteins;The activation of arylsulfatases;Gamma carboxylation, hypusine formation and arylsulfatase activation;Androgen and estrogen biosynthesis and metabolism;Metabolism;Glycosphingolipid metabolism;Sphingolipid metabolism
(Consensus)
Recessive Scores
- pRec
- 0.144
Intolerance Scores
- loftool
- 0.0885
- rvis_EVS
- 0.18
- rvis_percentile_EVS
- 66.07
Haploinsufficiency Scores
- pHI
- 0.424
- hipred
- N
- hipred_score
- 0.314
- ghis
- 0.478
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- Cellular component
- lysosome;endoplasmic reticulum lumen
- Molecular function
- arylsulfatase activity;metal ion binding